Treatment Experience – A mother’s story by The Coffee Klatch | Blog Talk Radio

For any parent raising a child affected by bipolar disorder, this is an invaluable interview. This interview provides a complete description of the FOH phenotype and clarifies the confusion caused by DSM controversies. An overview of the intranasal ketamine clinical study is presented by the study’s coordinator, Alyssa Bronsteen. MOST IMPORTANT: this is your chance…

Press Release: FDA Approval

Maplewood, NJ – November 3, 2011The Juvenile Bipolar Research Foundation (“JBRF”) announced today that the Federal Drug Administration (“FDA”) has approved its submission of a request to study the use of intranasal ketamine in the treatment of children ages 6-12 with bipolar disorder who also have an identifiable biological marker associated with body temperature dysregulation.…